SCHEMBL6115103

SCHEMBL6115103

CCCCS(=O)(=O)OCOS(=O)(=O)CCCC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 12/20 0.41
CA2 P00918 12/20 0.41
HPGD P15428 2/20 0.41
MAPK1 P28482 2/20 0.41
NPC1 O15118 1/20 0.41
S1PR2 O95136 1/20 0.41
S1PR4 O95977 1/20 0.41
ALDH1A1 P00352 1/20 0.41
LMNA P02545 1/20 0.41
TP53 P04637 1/20 0.41
POLB P06746 1/20 0.41
MAPT P10636 1/20 0.41
XBP1 P17861 1/20 0.41
S1PR1 P21453 1/20 0.41
AGTR1 P30556 1/20 0.41
HTT P42858 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
HSD17B10 Q99714 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11291963 0.92 FAAH (0.46) CA1CA2HPGDMAPK1CA9
SCHEMBL6114656 0.90 FAAH (0.50) CA1CA2HPGDMAPK1CA9
SCHEMBL10964774 0.90 FAAH (0.50) CA1CA2HPGDMAPK1CA9
SCHEMBL25630400 0.85 CA1 (0.45) CA1CA2HPGDMAPK1NPC1
SCHEMBL2382465 0.84 CA1 (0.42) CA1CA2HPGDMAPK1NPC1
SCHEMBL14733223 0.84 CA1 (0.46) CA1CA2HPGDMAPK1NPC1
SCHEMBL2836113 0.83 CA1 (0.36) CA1CA2HPGDMAPK1CA9
SCHEMBL26622186 0.83 CA1 (0.33) CA1CA2HPGDMAPK1NPC1
SCHEMBL14848947 0.83 CA1 (0.38) CA1CA2HPGDMAPK1NPC1
SCHEMBL23965433 0.82 CA1 (0.48) CA1CA2HPGDMAPK1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230198021-A1 ELECTROLYTIC SOLUTION FOR SECONDARY BATTERY, AND SECONDARY BATTERY MURATA MANUFACTURING CO., LTD. (JP) 2023-06-22 US disclosed
US-9912012-B2 Secondary battery, battery pack, electric vehicle, energy storage system, electric power tool, and electronic unit MURATA MANUFACTURING CO., LTD. (JP) 2018-03-06 US disclosed
US-20180048026-A1 SECONDARY BATTERY, ELECTROLYTIC SOLUTION, BATTERY PACK, ELECTRONIC DEVICE, AND ELECTRICAL VEHICLE TOHOKU MURATA MANUFACTURING CO., LTD. (JP) 2018-02-15 US disclosed
US-9806377-B2 Secondary battery, electrolytic solution, battery pack, electronic device, and electrical vehicle SONY CORPORATION (JP) 2017-10-31 US disclosed
US-20170200973-A1 ELECTROLYTIC SOLUTION, SECONDARY BATTERY, BATTERY PACK, ELECTRIC VEHICLE, ELECTRIC POWER STORAGE SYSTEM, ELECTRIC POWER TOOL, AND ELECTRONIC APPARATUS TOHOKU MURATA MANUFACTURING CO., LTD. (JP) 2017-07-13 US disclosed
US-20170170519-A1 SECONDARY BATTERY, BATTERY PACK, ELECTRIC VEHICLE, ENERGY STORAGE SYSTEM, ELECTRIC POWER TOOL, AND ELECTRONIC UNIT MURATA MANUFACTURING CO., LTD. (JP) 2017-06-15 US disclosed
US-9608289-B2 Electrolytic solution, secondary battery, battery pack, electric vehicle, electric power storage system, electric power tool, and electronic apparatus SONY CORPORATION (JP) 2017-03-28 US disclosed
EP-2602856-B1 NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE BATTERY USING SAME WAKO PURE CHEM IND LTD (JP) 2017-02-22 EP disclosed
EP-2602856-B1 NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE BATTERY USING SAME WAKO PURE CHEM IND LTD (JP) 2017-02-22 EP disclosed
US-9257720-B2 Nonaqueous electrolyte solution and nonaqueous electrolyte battery using same WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2016-02-09 US disclosed
US-20130089778-A1 ELECTROLYTIC SOLUTION, SECONDARY BATTERY, BATTERY PACK, ELECTRIC VEHICLE, ELECTRIC POWER STORAGE SYSTEM, ELECTRIC POWER TOOL, AND ELECTRONIC DEVICE SONY CORPORATION (JP) 2013-04-11 US disclosed
US-20130089779-A1 ELECTROLYTIC SOLUTION, SECONDARY BATTERY, BATTERY PACK, ELECTRIC VEHICLE, ELECTRIC POWER STORAGE SYSTEM, ELECTRIC POWER TOOL, AND ELECTRONIC DEVICE SONY CORPORATION (JP) 2013-04-11 US disclosed
US-20130059194-A1 ELECTROLYTIC SOLUTION FOR SECONDARY BATTERY, SECONDARY BATTERY, BATTERY PACK, ELECTRIC VEHICLE, ELECTRIC POWER STORAGE SYSTEM, ELECTRIC POWER TOOL, AND ELECTRONIC DEVICE SONY CORPORATION (JP) 2013-03-07 US disclosed
US-20130052543-A1 SECONDARY BATTERY, ELECTROLYTIC SOLUTION, BATTERY PACK, ELECTRONIC DEVICE, AND ELECTRICAL VEHICLE SONY CORPORATION (JP) 2013-02-28 US disclosed
EP-2463266-A1 PROCESS FOR PRODUCTION OF BIS-QUATERNARY AMMONIUM SALT, AND NOVEL INTERMEDIATE Wako Pure Chemical Industries, Ltd. (JP) 2012-06-13 EP disclosed
US-20120130107-A1 PROCESS FOR PRODUCTION OF BIS-QUATERNARY AMMONIUM SALT, AND NOVEL INTERMEDIATE WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2012-05-24 US disclosed
EP-0061313-B1 BIS-ESTERS OF 1,1-ALKANEDIOLS WITH 6-BETA-HYDROXYMETHYLPENICILLANIC ACID 1,1-DIOXIDE AND BETA-LACTAM ANTIBIOTICS PFIZER INC. (US) 1985-01-16 EP disclosed
US-4376076-A Bis-esters of 1,1-alkanediols with 6-beta-hydroxymethylpenicillanic acid 1,1-dioxide PFIZER INC. (US) 1983-03-08 US disclosed
EP-0061313-A2 Bis-esters of 1,1-alkanediols with 6-beta-hydroxymethylpenicillanic acid 1,1-dioxide and beta-lactam antibiotics PFIZER INC. (US) 1982-09-29 EP disclosed
US-4342768-A Bis-esters of 1,1-alkanediols with 6-beta-hydroxymethylpenicillanic acid 1,1-dioxide and beta-lactam antibiotics PFIZER INC. (US) 1982-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120130107-A1 PROCESS FOR PRODUCTION OF BIS-QUATERNARY AMMONIUM SALT, AND NOVEL INTERMEDIATE ASS1, C1S, FHIT CA1 163/4885CA2 83/4885HPGD 4481/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.